ZBH ZBH ジンマ―・バイオメット・ホ―ルディングス

 ZBHのチャート


 ZBHの企業情報

symbol ZBH
会社名 Zimmer Biomet Holdings Inc (ZBH ジンマ―・バイオメット・ホ―ルディングス)
分野(sector)   
産業(industry)   
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 ジマー・バイオメット・ホールディングス(Zimmer Biomet Holdings Inc.)は整形外科再建製品、スポーツ医学・生物製剤・四肢・外傷用製品、脊椎・骨治癒・頭蓋顎顔面・胸部用製品、歯科インプラント及び関連手術用製品の設計・製造・販売を行う。同社の製品とソリューションは骨・関節・支持軟組織疾患または損傷の患者の治療に使用される。同社は米国及び北・中・南米市場を含む米州、ヨーロッパ、中東及びアフリカ市場を含むEMEA及び日本と他のアジア・太平洋市場を含むアジア太平洋という3つの地域的セグメントを通じて事業を展開する。同社は米州脊椎、骨治癒、頭蓋顎顔面、歯科等の製品種類を有する。  ジンマ―・バイオメット・ホ―ルディングスは米国の医療器具持株会社。主に再建・整形外科用インプラント製品や外科製品を提供する。独自の「小柱網用金属」技術を組み込んだ人口関節製品、脊髄インプラント、関節・歯科用のインプラント、整形外科用の各種手術器具、機器を扱う。本社はインディアナ州。  Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
本社所在地 574 267-6131
代表者氏名 Bryan C. Hanson
代表者役職名 President Chief Executive Officer Director
電話番号 +1 574-267-6131
設立年月日 36892
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 19000人
url www.zimmer.com
nasdaq_url
adr_tso
EBITDA EBITDA(百万ドル) 2563.40000
終値(lastsale)
時価総額(marketcap)
時価総額 時価総額(百万ドル) 26124.81000
売上高 売上高(百万ドル) 7932.90000
企業価値(EV) 企業価値(EV)(百万ドル) 34520.71000
当期純利益 当期純利益(百万ドル) -370.90000
決算概要 決算概要 BRIEF: For the fiscal year ended 31 December 2018 Zimmer Biomet Holdings Inc revenues increased 2% to $7.93B. Net loss before extraordinary items totaled $370.9M vs. income of $541.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net loss reflects Goodwill impairment increase from $304.7M to $975.9M (expense) Selling general and administrative increase of 9% to $3.38B (expense).

 ZBHのテクニカル分析


 ZBHのニュース

   Joint Replacement Market 2022 Global Share, Growth, Size, Opportunities, Trends, Regional Overview, Leading Company Analysis, And Key Country Forecast To 2028 | Zimmer Biomet, Stryker, DePuy Synthes  2022/06/08 07:48:31 OpenPR
The Joint Replacement global market is thoroughly researched in this report, noting important aspects like market competition, global and regional growth, market segmentation and market structure. The report author analysts have estimated the size of the global market in terms
   Zimmer pans new firearms legislation  2022/06/01 15:22:17 PG Daily News
Prince George-Peace River-Northern Rockies MP, who has long lobbied against stricter firearms legislation, is slamming the last restrictions proposed by Ottawa. Zimmer, who is also co-chair of the Parliamentary Outdoor Caucus, says the new regulations show a lack of respect for the country’s outdoor community. The legislation, tabled earlier this week, include a national freeze […]
   Zimmer Biomet Holdings – Consensus Indicates Potential 9.0% Upside  2022/05/29 14:06:23 DirectorsTalk
Zimmer Biomet Holdings found using ticker (ZBH) now have 20 analysts in total covering the stock. The consensus rating is ''Hold''. The range between the high target price and low target price is between 145 and 114 calculating the average target price we see 131.55. With the stocks previous close at 120.65 this would imply there is a potential upside of 9.0%. There is a 50 day moving average of 123.11 and the 200 moving average now moves to 128.1. The company has a market capitalisation of $25,114m. Find out more information at: https://www.zimmerbiomet.com [stock_market_widget type="chart" template="basic" color="green" assets="ZBH" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $27,382m based on the market concensus. Zimmer Biomet Holdings, together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.
   ZBH stock cut to Hold at Needham on growth concerns (NYSE:ZBH)  2022/05/27 17:13:00 Seeking Alpha
Needham downgraded Zimmer Biomet (ZBH) to Hold from Buy, projecting Warsaw, Indiana-based maker of musculoskeletal reconstruction products to lag peers in terms of revenue and…
   Surgical Robots Market, a $20.98 Billion Industry by 2030 with a CAGR of 16.84% - Strategic Market Research  2022/05/27 15:10:06 Benzinga
New York, United States, May 27, 2022 (GLOBE NEWSWIRE) -- Surgical robots are regarded as the highly advanced technological robots that allows the surgeons to perform surgeries in the human body through small incisions. The surgical robots also allow the surgeons to perform different types of complex surgical operations with more flexibility, precision, and control as compared to the conventional techniques. In terms of End-User, the Hospital segment accounted for the highest share of around 71.22% in 2020 & in terms of region, North America led the market with a share of around 67.98%. However, the Asia-Pacific region witnessed the fastest market growth rate, with a promising CAGR of around 23.32%. To get a first-hand overview of the report, Request a Sample at https://www.strategicmarketresearch.com/request-sample/surgical-robots-market The report broadcasted by Strategic Market Research on Surgical Robots Market is ramified based on: Application Orthopedics Neurology Urology Gynaecology General Surgery Others End-User Hospitals Ambulatory Surgical Centres Others Regions: North America USA Mexico Canada Rest of North America Europe Germany France Russia Switzerland U.K Finland Turkey Netherlands Belgium Spain Italy Rest of Europe Asia Pacific China India Indonesia Thailand Japan South Korea Singapore Malaysia Philippines Australia New Zealand Rest of APAC LAMEA Brazil Saudi Arabia Uruguay Argentina Rest of LAMEA Make a Direct Purchase of the latest Surgical Robots Market Report published in the month of April 2022.
   The Global Orthopedic Trauma Devices Market is Anticipated to Surge at a CAGR of 6.41% Reaching USD 10.08 Billion by 2026, Analyzes DelveInsight  2022/05/05 17:00:00 Benzinga
New York, USA, May 05, 2022 (GLOBE NEWSWIRE) -- The Global Orthopedic Trauma Devices Market is Anticipated to Surge at a CAGR of 6.41% Reaching USD 10.08 Billion by 2026, Analyzes DelveInsight The Orthopedic Trauma Devices market is expected to boost owing to the rising incidence of trauma and accident cases, the increasing prevalence of degenerative bone disorders, the increasing number of sports-related injuries, rising technological advancements pertaining to orthopedic trauma devices, and the rising number of new product launches, among others. According to the latest report published by DelveInsight, " Orthopedic Trauma Devices Market Insight Report ," the global Orthopedic Trauma Devices market is expected to witness significant growth owing to an increase in the prevalence of simple fractures and severe life-threatening injuries. Furthermore, the rising number of accidents or other fatal incidences, along with the rising number of trauma associated with road accidents, fall injuries, and the increasing prevalence pertaining to osteoarthritis and orthopedic sports injury, is also a major factor contributing to the growth of Orthopedic Trauma Devices market.
   SVB Leerink Maintains Outperform Rating for Zimmer Biomet Holdings: Here''s What You Need To Know  2022/05/04 16:14:40 Benzinga
SVB Leerink has decided to maintain its Outperform rating of Zimmer Biomet Holdings (NYSE: ZBH ) and raise its price target from $135.00 to $140.00. Shares of Zimmer Biomet Holdings are trading up 0.82% over the last 24 hours, at $121.67 per share. A move to $140.00 would account for a 15.06% increase from the current share price. About Zimmer Biomet Holdings Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in … Full story available on Benzinga.com
   Zimmer Biomet Raises, Tightens FY22 Outlook after Q1 Earnings Surpass Estimates  2022/05/03 17:57:38 Benzinga
Zimmer Biomet Holdings Inc''s (NYSE: ZBH ) Q1 sales increased by 3.9% Y/Y to $1.66 billion (up 6.8% on a constant currency basis), beating the consensus of $1.59 billion. Adjusted EPS was $1.61, which came in above the consensus of $1.41 and $1.55 a year ago. "We are encouraged by the better than … Full story available on Benzinga.com
   Zimmer Biomet Holdings Inc. (ZBH) CEO Bryan Hanson on Q1 2022 Results - Earnings Call Transcript  2022/05/03 17:03:05 Seeking Alpha
Zimmer Biomet Holdings Inc Q1 2022 Earnings Conference Call May 3, 2022, 8:30 AM ET Company Participants Bryan Hanson – Chairman, President, and Chief Executive Officer Suky Upadhyay –…
   Zimmer Biomet: Q1 Earnings Insights  2022/05/03 11:23:28 Benzinga
Zimmer Biomet Holdings (NYSE: ZBH ) reported its Q1 earnings results on Tuesday, May 3, 2022 at 06:30 AM. Here''s what investors need to know about the announcement. Earnings Zimmer Biomet Holdings beat estimated earnings by 14.18%, reporting an EPS of $1.61 … Full story available on Benzinga.com
   Combined Physical Therapy Device Market 2021: Strategic Assessment, Latest Innovations, Drivers, Restraints, Challenges to 2027 | BTL Corporate, Zimmer MedizinSysteme GmbH  2021/07/02 09:07:53 OpenPR
An extensive study offering forecast assessment on Combined Physical Therapy Device Market has been broadcasted. By correlating the historical data with key market dynamics, our analysts can make highly astute projections. The report includes a thorough analysis of the global
   Zimmer Biomet announces partnership with OSSIS as exclusive Asia Pacific distributor for patient-specific 3D printed titanium hip replacement joints  2021/07/01 00:00:00 PR Newswire Asia (English)
SINGAPORE , July 1, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced a partnership with OSSIS to serve as the exclusive Asia Pacific distributor for its patient-specific 3D printed titanium hip replacement joints. OSSIS, a New Zealand based company, specializes in complex hip replacements including second-time hip replacement, and replacement involving bone tumours and trauma. "This partnership will allow Zimmer Biomet to provide our extensive network of orthopaedic surgeons with the option of patient-specific implants which are crafted with a combination of clinical and engineering expertise," said Sang Yi , Zimmer Biomet Asia Pacific Group President. "This will further strengthen Zimmer Biomet''s extensive portfolio of revision hip solutions and complementary technologies, with the ultimate goal of providing innovative solutions for complex cases and improving the quality of life of patients." "The partnership with Zimmer Biomet will enhance OSSIS'' ability to support surgeons and patients alike and create a network across the Asia Pacific region of cutting-edge technology and expert capability, " said OSSIS Managing Director , Kelvin Hyland . "This is an exciting step for OSSIS.
   Pneumatic Compression Therapy Market Report- Trends, Growth Demand, Opportunities & Forecast | ArjoHuntleigh , Zimmer Biomet Holdings Inc  2021/06/30 12:55:50 Jumbo News
Pneumatic Compression Therapy Market research report helps in gathering and analysing useful insights such as global market size, forecast and Compound Annual Growth Rate (CAGR) of a particular industry. It also helps in determining the market status, future prospects, growth opportunity, main challenges about the market for any industry. Pneumatic Compression Therapy Market research report []
   2021 Medical Tourism Market Report- Global Industry Analysis | Vitrolife, Zimmer Biomet Holdings Inc  2021/06/30 08:46:00 Jumbo News
ReportsnReports added Medical Tourism Market Research Report created by Report Consultant, which offers detailed insights, revenue details, and other information regarding the global market, and the various trends, drivers, restraints, opportunities, and market till 2028. Medical Tourism Market Report offers detailed information regarding the leading key players operating in the market, their financials, supply chain []
   Dental Laboratories Market 2020: Research In-Depth Analysis, Market Applications, Key End-Users Forecasts To 2027 by Company Profiles: Dentsply Sirona, Zimmer Biomet, BEGO GmbH, Ultradent Products, GC Corporation, Ivoclar Vivadent  2021/06/30 06:00:47 OpenPR
Dental laboratories market is anticipated to reach US$ 54,008.10 Mn in 2027 from US$ 33,264.24 Mn in 2018. The market is expected to grow with a CAGR of 5.7% from 2019-2027. A Latest intelligence report published by The Insight Partners with

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 ZBH ジンマ―・バイオメット・ホ―ルディングス ZBH )

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)